Market Overview

UPDATE: Morgan Stanley Cuts PT to $42 on MetLife Following Guidance

Share:
Related MET
Insurance Stocks May Have Risen Too Far Too Fast
The Market In 5 Minutes: Castro, Trump And Oil In Focus
Financials and energy surge again, tech continues slump (Seeking Alpha)

Morgan Stanley reiterated its Overweight rating on MetLife (NYSE: MET) but lowered its price target from $44 to $42.

Morgan Stanley noted, "MetLife's guidance was modestly disappointing, with both EPS and capital expectations running somewhat below our expectations. That said, their guidance is typically conservative (they typically hit at least the high end), and even with lowered numbers, the valuation multiple on stock is very low."

MetLife closed at $33.61 on Wednesday.

Latest Ratings for MET

DateFirmActionFromTo
Nov 2016FBR CapitalDowngradesOutperformMarket Perform
Oct 2016Credit SuisseInitiates Coverage onNeutral
Jul 2016Deutsche BankDowngradesBuyHold

View More Analyst Ratings for MET
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (MET)

View Comments and Join the Discussion!